326030.KS

Fairly Valued

SK Biopharmaceuticals Co., Ltd. — PEG Ratio Analysis

1.88

PEG Ratio

1.88

Growth Rate Source

Limited Data Quality1-Year EPS CAGR

Current Price

$89700.00

TTM EPS

$4279.13

P/E Ratio

20.96

Growth Rate

11.1%

1-Year EPS CAGR

Sector

Healthcare

Biotechnology

Calculated

6/17/2026

9:15:33 AM

Peer Comparison

Sample Size

4 peers

Industry Median PEG

4.02

25th Percentile

1.67

75th Percentile

80.02

326030.KS PEG (1.88) vs Industry Median (4.02): 53% discount

Symbol	Company	PEG	P/E	Growth	vs 326030.KS
207940.KS	Samsung Biologics Co.,Ltd.	0.56	33.8	60.7%	-70%
035720.KS	Kakao Corp.	1.67	40.2	24.1%	-11%
068270.KS	Celltrion, Inc.	6.38	28.9	4.5%	+239%
000100.KS	Yuhan Corporation	80.02	33.6	0.4%	+4154%

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.